Medtronic plc (MDT)

IE — Healthcare Sector
Peers:   EW  ABT  BSX  ZBH  SYK  DXCM  PODD  TNDM  ALGN 

Automate Your Wheel Strategy on MDT

With Tiblio's Option Bot, you can configure your own wheel strategy including MDT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol MDT
  • Rev/Share 25.8882
  • Book/Share 38.6892
  • PB 2.1744
  • Debt/Equity 0.5387
  • CurrentRatio 1.9014
  • ROIC 0.0615

 

  • MktCap 107399899600.0
  • FreeCF/Share 4.2631
  • PFCF 19.6451
  • PE 25.2085
  • Debt/Assets 0.2957
  • DivYield 0.0334
  • ROE 0.0869

 

  • Rating B
  • Score 3
  • Recommendation Neutral
  • P/E Score 1
  • DCF Score 4
  • P/B Score 2
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Upgrade MDT Citigroup Neutral Buy $92 $107 March 4, 2025
Upgrade MDT RBC Capital Mkts Sector Perform Outperform $98 $105 Oct. 10, 2024
Reiterated MDT Oppenheimer -- Perform $92 $94 Aug. 21, 2024

News

Dividend Kings Of The Future
BEN, CLX, CSL, CTBI, MCD, MDT, MGEE, RLI, SHW
Published: March 18, 2025 by: Seeking Alpha
Sentiment: Positive

A list of 9 companies that may reach Dividend King status in the near future. These companies span various sectors and offer investors a wide range of dividend growth rates and yields. A few of these companies have abnormally high payout ratios, which may hinder their ability to achieve Dividend King status.

Read More
image for news Dividend Kings Of The Future
Why Medtronic (MDT) is a Top Momentum Stock for the Long-Term
MDT
Published: March 18, 2025 by: Zacks Investment Research
Sentiment: Positive

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read More
image for news Why Medtronic (MDT) is a Top Momentum Stock for the Long-Term
NVIDIA's AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus
GEHC, MDT, RMD
Published: March 12, 2025 by: Zacks Investment Research
Sentiment: Positive

RMD, GEHC and MDT are expected to thrive as NVIDIA and other AI leaders' MedTech ventures accelerate digital adoption within the space.

Read More
image for news NVIDIA's AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus
The Big 3: KO, MDT, LHX
KO, LHX, MDT
Published: March 11, 2025 by: Schwab Network
Sentiment: Positive

Stability is Kenny Polcari's theme when it comes to today's Big 3. He explains why Cola-Cola (KO), Medtronic (MDT) and L3Harris (LHX) are undervalued names with quality.

Read More
image for news The Big 3: KO, MDT, LHX
Positive Trial Data on Evolut TAVR Likely to Support MDT Stock
MDT
Published: March 10, 2025 by: Zacks Investment Research
Sentiment: Positive

At the CRT conference 2025, Medtronic presented two-year favorable SMART trial data, which demonstrated the superior performance of the Evolut TAVR valve in patients with AS.

Read More
image for news Positive Trial Data on Evolut TAVR Likely to Support MDT Stock
Medtronic explores options to optimize manufacturing operations amid Trump's tariff threats
MDT
Published: February 25, 2025 by: Reuters
Sentiment: Neutral

Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U.S. President Donald Trump's tariff plans, a company executive told Reuters on Tuesday.

Read More
image for news Medtronic explores options to optimize manufacturing operations amid Trump's tariff threats
Distributor Purchasing Shifts Mar MDT's Q3 Show: How to Play the Stock
MDT
Published: February 24, 2025 by: Zacks Investment Research
Sentiment: Negative

Medtronic's Medical Surgical segment faces challenges in the third quarter due to shifts in U.S. distributor buying patterns.

Read More
image for news Distributor Purchasing Shifts Mar MDT's Q3 Show: How to Play the Stock
Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's
MDT
Published: February 24, 2025 by: PRNewsWire
Sentiment: Neutral

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever GALWAY, Ireland , Feb. 24, 2025 /PRNewswire/ -- For the one million people diagnosed with Parkinson's disease in the United States 1, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug Administration (FDA) approval of BrainSense™ Adaptive deep brain stimulation (aDBS) and BrainSense™ Electrode Identifier (EI). There is no cure for debilitating neurological conditions like Parkinson's, however, deep brain stimulation (DBS) has been transforming the lives of people with Parkinson's and other …

Read More
image for news Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's
Medtronic's Expansion Gains Momentum—Time for a Market Shift?
MDT
Published: February 21, 2025 by: MarketBeat
Sentiment: Positive

Medtronic's NYSE: MDT growth efforts and investments in medical technology innovation are starting to pay off. The company's pulsed field ablation (PFA) technology is a key growth driver, strengthening both its cardiac segment and overall business expansion.

Read More
image for news Medtronic's Expansion Gains Momentum—Time for a Market Shift?
The Smartest Dividend Stocks to Buy With $1,000 Right Now
MDT, PFE, UPS, VICI, VZ
Published: February 20, 2025 by: The Motley Fool
Sentiment: Positive

You have $1,000 (or $200 or $50,000) burning a hole in your pocket and you're itching to invest in some stocks. Might I suggest some dividend payers?

Read More
image for news The Smartest Dividend Stocks to Buy With $1,000 Right Now
Why Medtronic Stock Is Sinking Today
MDT
Published: February 18, 2025 by: The Motley Fool
Sentiment: Negative

Shares of Medtronic (MDT -6.63%) were sinking 7.3% as of 11:21 a.m. ET on Tuesday.

Read More
image for news Why Medtronic Stock Is Sinking Today
Empire State Manufacturing Increase More Than Expected
BIDU, MDT
Published: February 18, 2025 by: Zacks Investment Research
Sentiment: Positive

Pre-market futures are starting a new holiday-shortened trading week higher, with all four major indexes currently riding in the green. The Dow is +81 points at this hour, the S&P 500 is +23, the Nasdaq +96 points and the small-cap Russell 2000 +9.

Read More
image for news Empire State Manufacturing Increase More Than Expected
Medtronic plc (MDT) Q3 2025 Earnings Call Transcript
MDT
Published: February 18, 2025 by: Seeking Alpha
Sentiment: Neutral

Medtronic plc (NYSE:MDT ) Q3 2025 Earnings Conference Call February 18, 2025 8:00 AM ET Company Participants Ryan Weispfenning - Vice President and Head of Investor Relations Geoff Martha - Chairman and Chief Executive Officer Gary Corona - Interim Chief Financial Officer Brad Welnick - Vice President, Investor Relations Sean Salmon - Executive Vice President and President, Cardiovascular Portfolio Mike Marinaro - Executive Vice President and President, Medical Surgical Portfolio and Americas Conference Call Participants Patrick Wood - Morgan Stanley Larry Biegelsen - Wells Fargo Robbie Marcus - JP Morgan Vijay Kumar - Evercore ISI Travis Steed - Bank of …

Read More
image for news Medtronic plc (MDT) Q3 2025 Earnings Call Transcript
Medtronic (MDT) Tops Q3 Earnings Estimates
MDT
Published: February 18, 2025 by: Zacks Investment Research
Sentiment: Positive

Medtronic (MDT) came out with quarterly earnings of $1.39 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.30 per share a year ago.

Read More
image for news Medtronic (MDT) Tops Q3 Earnings Estimates
Medtronic (MDT) Increases Yet Falls Behind Market: What Investors Need to Know
MDT
Published: February 13, 2025 by: Zacks Investment Research
Sentiment: Neutral

In the closing of the recent trading day, Medtronic (MDT) stood at $92.20, denoting a +0.93% change from the preceding trading day.

Read More
image for news Medtronic (MDT) Increases Yet Falls Behind Market: What Investors Need to Know
3 High-Yield Dividend Stocks I Can't Wait to Buy to Boost My Passive Income
ENB, MDT, VICI
Published: February 13, 2025 by: The Motley Fool
Sentiment: Positive

I'm about to get a big cash infusion in my portfolio. Last year, private equity giant Blackstone agreed to buy one of my holdings, Retail Opportunity Investments Corp. , in an all-cash deal.

Read More
image for news 3 High-Yield Dividend Stocks I Can't Wait to Buy to Boost My Passive Income
Retirement Strategy: 2 Dividend Aristocrats At Bargain Prices
MDT, MO
Published: February 12, 2025 by: Seeking Alpha
Sentiment: Positive

Buying battle-tested dividend aristocrats can be a winning strategy for those seeking durable retirement income. What's even better is if they also carry strong balance sheets and are attractively valued. In this article, I highlight 2 such picks, which, on a combined basis, offer immediate diversification and potential for market-beating total returns.

Read More
image for news Retirement Strategy: 2 Dividend Aristocrats At Bargain Prices
MDT Stock Trades Cheaper Than Peers Ahead of Q3 Earnings: Time to Buy?
MDT
Published: February 11, 2025 by: Zacks Investment Research
Sentiment: Negative

Medtronic expects its fiscal 2025 third-quarter revenues to reflect an unfavorable impact of 1% from currency translation.

Read More
image for news MDT Stock Trades Cheaper Than Peers Ahead of Q3 Earnings: Time to Buy?

About Medtronic plc (MDT)

  • IPO Date 1973-05-02
  • Website https://www.medtronic.com
  • Industry Medical - Devices
  • CEO Mr. Geoffrey Straub Martha
  • Employees 95000

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.